Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023

Detalhes bibliográficos
Autor(a) principal: Mendonça Horato, Caroline
Data de Publicação: 2023
Outros Autores: Carlos Santos da Costa, Jorge
Tipo de documento: Artigo
Idioma: por
Título da fonte: Vigilância Sanitária em Debate
Texto Completo: https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2182
Resumo: Introduction: Due to health regulations, the quality management system in pharmaceutical companies is compulsory and regularly evaluated by health bodies in relation to GMP supervision. However, health regulation does not extend to concerns about occupational health and safety and the environment. It is important to mature the management systems for these issues. Objective: To study the integration potential of occupational health and safety systems, environment and quality of pharmaceutical laboratories, considering the assumptions, regulatory requirements and particularities of the segment. Method: Exploratory and descriptive study carried out through documentary and field research. Matrixes of requirements of the thematic standards were built and mapped, and actions for integration were proposed. After that, they were submitted to the evaluation by specialists. Results: Comparing the RDC 301/2019 and 652/2022 with the ICH Q10, ISO 9001, 45001 and 14001, it was found that for 71% of the themes and normative requirements, there is synergy and total convergence between the requirements. For the other items, it is necessary to adapt processes and conducts. The propositions listed by the authors to address the gaps were positively validated in relation to achieving implementation feasibility in about 90%. In relation to the positive benefit, the evaluation was unanimous in 100%, and for the implementation of the resources listed, in 66% of the points there is a need for great institutional effort. Conclusions: The integration of a management system that incorporates the themes quality, health and safety and the environment is possible and beneficial for the pharmaceutical industry and supports the definition of strategies, prioritization of actions and allocation of resources.
id FIOCRUZ-9_34dc8f0bd0d2d5e07b3c5f78ad90e04c
oai_identifier_str oai:ojs.visaemdebate.incqs.fiocruz.br:article/2182
network_acronym_str FIOCRUZ-9
network_name_str Vigilância Sanitária em Debate
repository_id_str
spelling Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023Integração de processos dos sistemas gestão da qualidade, segurança e saúde ocupacional, meio ambiente em laboratórios farmacêuticos: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Publicado em: 21/12/2023Sistema de Gestão IntegradaIndústria FarmacêuticaQualidade FarmacêuticaIntegrated Management System Pharmaceutical IndustryPharmaceutical QualityIntroduction: Due to health regulations, the quality management system in pharmaceutical companies is compulsory and regularly evaluated by health bodies in relation to GMP supervision. However, health regulation does not extend to concerns about occupational health and safety and the environment. It is important to mature the management systems for these issues. Objective: To study the integration potential of occupational health and safety systems, environment and quality of pharmaceutical laboratories, considering the assumptions, regulatory requirements and particularities of the segment. Method: Exploratory and descriptive study carried out through documentary and field research. Matrixes of requirements of the thematic standards were built and mapped, and actions for integration were proposed. After that, they were submitted to the evaluation by specialists. Results: Comparing the RDC 301/2019 and 652/2022 with the ICH Q10, ISO 9001, 45001 and 14001, it was found that for 71% of the themes and normative requirements, there is synergy and total convergence between the requirements. For the other items, it is necessary to adapt processes and conducts. The propositions listed by the authors to address the gaps were positively validated in relation to achieving implementation feasibility in about 90%. In relation to the positive benefit, the evaluation was unanimous in 100%, and for the implementation of the resources listed, in 66% of the points there is a need for great institutional effort. Conclusions: The integration of a management system that incorporates the themes quality, health and safety and the environment is possible and beneficial for the pharmaceutical industry and supports the definition of strategies, prioritization of actions and allocation of resources.Introdução: Por conta da regulamentação sanitária, o sistema de gestão da qualidade nas indústrias farmacêuticas é compulsório e regularmente avaliado pelos órgãos sanitários com relação à adequação às boas práticas de fabricação (BPF). Entretanto, a regulamentação sanitária não se estende às preocupações com a saúde e segurança ocupacional e com o meio ambiente. É importante amadurecer os sistemas de gestão destas temáticas. Objetivo: Estudar a potencialidade de integração dos sistemas de segurança e saúde ocupacional, meio ambiente e qualidade de laboratórios farmacêuticos levando em consideração as premissas, os requisitos regulatórios e as particularidades do segmento. Método: Estudo exploratório e descritivo realizado por meio de pesquisa documental e de campo. Foram construídas matrizes de correlação de requisitos das normas temáticas, mapeadas e propostas ações para integração e em sequência submetida a avaliação por especialistas. Resultados: Comparando as RDC n° 301/2019 e n° 652/2022 com o ICH Q10, ISO 9001, 45001 e 14001, constatou-se que, para 71% dos temas e requisitos normativos, há sinergia e convergência total entre os requerimentos. Para os demais itens são necessárias adequações de processos e condutas. As proposições elencadas pelos autores para tratar as lacunas foram validadas positivamente com relação ao parâmetro viabilidade de implementação em cerca de 90%. Com relação ao benefício positivo, a avaliação foi unânime em 100% e, para a concretização dos tópicos elencados, para 66% dos pontos há necessidade de grande esforço institucional. Conclusões: A integração de um sistema de gestão que incorpore as temáticas qualidade, saúde e segurança e meio ambiente é possível e benéfica para a indústria farmacêutica e suportaria a definição de estratégias, priorizações de ações e alocação de recursos.Instituto Nacional de Controle de Qualidade em Saúde2023-12-21info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/218210.22239/2317-269x.02182Health Surveillance under Debate: Society, Science & Technology ; v. 11 (2023) | Continuous publication; 1-11Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; v. 11 (2023) | Publicación continua; 1-11Vigil Sanit Debate, Rio de Janeiro; v. 11 (2023) | Publicação contínua; 1-112317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2182/1595Copyright (c) 2023 Caroline Mendonça Horato, Jorge Carlos Santos da Costa (Autor)https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMendonça Horato, CarolineCarlos Santos da Costa, Jorge2023-12-21T19:04:43Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/2182Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2023-12-21T19:04:43Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.none.fl_str_mv Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023
Integração de processos dos sistemas gestão da qualidade, segurança e saúde ocupacional, meio ambiente em laboratórios farmacêuticos: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Publicado em: 21/12/2023
title Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023
spellingShingle Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023
Mendonça Horato, Caroline
Sistema de Gestão Integrada
Indústria Farmacêutica
Qualidade Farmacêutica
Integrated Management System
Pharmaceutical Industry
Pharmaceutical Quality
title_short Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023
title_full Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023
title_fullStr Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023
title_full_unstemmed Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023
title_sort Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023
author Mendonça Horato, Caroline
author_facet Mendonça Horato, Caroline
Carlos Santos da Costa, Jorge
author_role author
author2 Carlos Santos da Costa, Jorge
author2_role author
dc.contributor.author.fl_str_mv Mendonça Horato, Caroline
Carlos Santos da Costa, Jorge
dc.subject.por.fl_str_mv Sistema de Gestão Integrada
Indústria Farmacêutica
Qualidade Farmacêutica
Integrated Management System
Pharmaceutical Industry
Pharmaceutical Quality
topic Sistema de Gestão Integrada
Indústria Farmacêutica
Qualidade Farmacêutica
Integrated Management System
Pharmaceutical Industry
Pharmaceutical Quality
description Introduction: Due to health regulations, the quality management system in pharmaceutical companies is compulsory and regularly evaluated by health bodies in relation to GMP supervision. However, health regulation does not extend to concerns about occupational health and safety and the environment. It is important to mature the management systems for these issues. Objective: To study the integration potential of occupational health and safety systems, environment and quality of pharmaceutical laboratories, considering the assumptions, regulatory requirements and particularities of the segment. Method: Exploratory and descriptive study carried out through documentary and field research. Matrixes of requirements of the thematic standards were built and mapped, and actions for integration were proposed. After that, they were submitted to the evaluation by specialists. Results: Comparing the RDC 301/2019 and 652/2022 with the ICH Q10, ISO 9001, 45001 and 14001, it was found that for 71% of the themes and normative requirements, there is synergy and total convergence between the requirements. For the other items, it is necessary to adapt processes and conducts. The propositions listed by the authors to address the gaps were positively validated in relation to achieving implementation feasibility in about 90%. In relation to the positive benefit, the evaluation was unanimous in 100%, and for the implementation of the resources listed, in 66% of the points there is a need for great institutional effort. Conclusions: The integration of a management system that incorporates the themes quality, health and safety and the environment is possible and beneficial for the pharmaceutical industry and supports the definition of strategies, prioritization of actions and allocation of resources.
publishDate 2023
dc.date.none.fl_str_mv 2023-12-21
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
"Peer-reviewed article"
"Artículo revisado por pares"
"Artigo avaliado pelos pares"
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2182
10.22239/2317-269x.02182
url https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2182
identifier_str_mv 10.22239/2317-269x.02182
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2182/1595
dc.rights.driver.fl_str_mv Copyright (c) 2023 Caroline Mendonça Horato, Jorge Carlos Santos da Costa (Autor)
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Caroline Mendonça Horato, Jorge Carlos Santos da Costa (Autor)
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Instituto Nacional de Controle de Qualidade em Saúde
publisher.none.fl_str_mv Instituto Nacional de Controle de Qualidade em Saúde
dc.source.none.fl_str_mv Health Surveillance under Debate: Society, Science & Technology ; v. 11 (2023) | Continuous publication; 1-11
Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; v. 11 (2023) | Publicación continua; 1-11
Vigil Sanit Debate, Rio de Janeiro; v. 11 (2023) | Publicação contínua; 1-11
2317-269X
reponame:Vigilância Sanitária em Debate
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Vigilância Sanitária em Debate
collection Vigilância Sanitária em Debate
repository.name.fl_str_mv Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br
_version_ 1797042047313510400